The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia
We studied the role of NO synthase in the infarct-limiting effect of short-term (SNH) and chronic continuous normobaric hypoxia (CNH). In male Wistar rats, SNH (6 sessions of 10-min hypoxia 8% O2 and 10-min reoxygenation) or CNH (12% O2 for 21 days) was modeled. In 30 min after SNH or 24 h after CNH...
Gespeichert in:
Veröffentlicht in: | Bulletin of experimental biology and medicine 2023, Vol.174 (3), p.304-307 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 307 |
---|---|
container_issue | 3 |
container_start_page | 304 |
container_title | Bulletin of experimental biology and medicine |
container_volume | 174 |
creator | Naryzhnaya, N. V. Sementsov, A. S. Maslov, L. N. Derkachev, I. A. |
description | We studied the role of NO synthase in the infarct-limiting effect of short-term (SNH) and chronic continuous normobaric hypoxia (CNH). In male Wistar rats, SNH (6 sessions of 10-min hypoxia 8% O2 and 10-min reoxygenation) or CNH (12% O2 for 21 days) was modeled. In 30 min after SNH or 24 h after CNH, the rats were subjected to coronary artery occlusion (45 min) and reperfusion (2 h). The following drugs were administered to rats: non-selective NO synthase inhibitor L-NAME (10 mg/kg), inhibitor of inducible NO synthase S-methylthiourea (3 mg/kg), and inhibitor of neuronal NO-synthase 7-nitroindazole (50 mg/kg). NO donor diethylenetriamine was administered intravenously in a dose 2 mg/kg. It was found that L-NAME and S-methylthiourea abolished the infarct-limiting effect of SNH and CNH. Diethylenetriamine increased cardiac tolerance to ischemia/reperfusion. It is believed that inducible NO synthase plays an important role in the cardioprotective effect of normobaric hypoxia. |
doi_str_mv | 10.1007/s10517-023-05696-3 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2771637628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A744168313</galeid><sourcerecordid>A744168313</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-c5a229413531acb1b386e8a262e3cb4e633f0ee21cb3c73e73bdfbeb5314d4493</originalsourceid><addsrcrecordid>eNp9klFrFDEUhQdR7Fr9Az5IQBBfpia5mcns47JUW1ha0PY5ZDJ3dlNmkjXJQPffm3GrtSKSh5Dc7xzuTU5RvGX0jFEqP0VGKyZLyqGkVb2sS3hWLFgloWw4Z8-LBc1UKZqmOSlexXg3H2nNXhYnUEsOEsSiGG92SL76AYnvydU1-XZwaacjEutIyqVL1-tgUrmxo03Wbcl536NJM30btugS0a4j613wzhqy6vQ-6WR9Fnty5cPoWx1y4eKw9_dWvy5e9HqI-OZhPy1uP5_frC_KzfWXy_VqUxqoRCpNpTlfCgYVMG1a1kJTY6N5zRFMK7AG6CkiZ6YFIwEltF3fYptx0QmxhNPi49F3H_z3CWNSo40Gh0E79FNUXEpWg6x5k9H3f6F3fgoudzdTQtKGVeyR2uoBlXW9T0Gb2VStpBCsboBBps7-QeXV4WiNd9jbfP9E8OEPwQ71kHbRD9P8gvEpyI-gCT7GgL3aBzvqcFCMqjkM6hgGlcOgfoZBzaJ3D6NN7Yjdb8mv388AHIGYS26L4XH2_9j-AFIVu8U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2774708151</pqid></control><display><type>article</type><title>The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Naryzhnaya, N. V. ; Sementsov, A. S. ; Maslov, L. N. ; Derkachev, I. A.</creator><creatorcontrib>Naryzhnaya, N. V. ; Sementsov, A. S. ; Maslov, L. N. ; Derkachev, I. A.</creatorcontrib><description>We studied the role of NO synthase in the infarct-limiting effect of short-term (SNH) and chronic continuous normobaric hypoxia (CNH). In male Wistar rats, SNH (6 sessions of 10-min hypoxia 8% O2 and 10-min reoxygenation) or CNH (12% O2 for 21 days) was modeled. In 30 min after SNH or 24 h after CNH, the rats were subjected to coronary artery occlusion (45 min) and reperfusion (2 h). The following drugs were administered to rats: non-selective NO synthase inhibitor L-NAME (10 mg/kg), inhibitor of inducible NO synthase S-methylthiourea (3 mg/kg), and inhibitor of neuronal NO-synthase 7-nitroindazole (50 mg/kg). NO donor diethylenetriamine was administered intravenously in a dose 2 mg/kg. It was found that L-NAME and S-methylthiourea abolished the infarct-limiting effect of SNH and CNH. Diethylenetriamine increased cardiac tolerance to ischemia/reperfusion. It is believed that inducible NO synthase plays an important role in the cardioprotective effect of normobaric hypoxia.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-023-05696-3</identifier><identifier>PMID: 36723734</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Analysis ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Coronary artery ; General Pathology and Pathological Physiology ; Heart ; Hemoglobin ; Hypoxia ; Internal Medicine ; Ischemia ; Laboratory Medicine ; Male ; Myocardial Infarction ; Myocardial Reperfusion Injury - drug therapy ; NG-Nitroarginine methyl ester ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric Oxide Synthase ; Pathology ; Physiology ; Rats ; Rats, Wistar ; Reperfusion</subject><ispartof>Bulletin of experimental biology and medicine, 2023, Vol.174 (3), p.304-307</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>COPYRIGHT 2023 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c354t-c5a229413531acb1b386e8a262e3cb4e633f0ee21cb3c73e73bdfbeb5314d4493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10517-023-05696-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10517-023-05696-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36723734$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Naryzhnaya, N. V.</creatorcontrib><creatorcontrib>Sementsov, A. S.</creatorcontrib><creatorcontrib>Maslov, L. N.</creatorcontrib><creatorcontrib>Derkachev, I. A.</creatorcontrib><title>The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>We studied the role of NO synthase in the infarct-limiting effect of short-term (SNH) and chronic continuous normobaric hypoxia (CNH). In male Wistar rats, SNH (6 sessions of 10-min hypoxia 8% O2 and 10-min reoxygenation) or CNH (12% O2 for 21 days) was modeled. In 30 min after SNH or 24 h after CNH, the rats were subjected to coronary artery occlusion (45 min) and reperfusion (2 h). The following drugs were administered to rats: non-selective NO synthase inhibitor L-NAME (10 mg/kg), inhibitor of inducible NO synthase S-methylthiourea (3 mg/kg), and inhibitor of neuronal NO-synthase 7-nitroindazole (50 mg/kg). NO donor diethylenetriamine was administered intravenously in a dose 2 mg/kg. It was found that L-NAME and S-methylthiourea abolished the infarct-limiting effect of SNH and CNH. Diethylenetriamine increased cardiac tolerance to ischemia/reperfusion. It is believed that inducible NO synthase plays an important role in the cardioprotective effect of normobaric hypoxia.</description><subject>Analysis</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Coronary artery</subject><subject>General Pathology and Pathological Physiology</subject><subject>Heart</subject><subject>Hemoglobin</subject><subject>Hypoxia</subject><subject>Internal Medicine</subject><subject>Ischemia</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Myocardial Infarction</subject><subject>Myocardial Reperfusion Injury - drug therapy</subject><subject>NG-Nitroarginine methyl ester</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric Oxide Synthase</subject><subject>Pathology</subject><subject>Physiology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reperfusion</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9klFrFDEUhQdR7Fr9Az5IQBBfpia5mcns47JUW1ha0PY5ZDJ3dlNmkjXJQPffm3GrtSKSh5Dc7xzuTU5RvGX0jFEqP0VGKyZLyqGkVb2sS3hWLFgloWw4Z8-LBc1UKZqmOSlexXg3H2nNXhYnUEsOEsSiGG92SL76AYnvydU1-XZwaacjEutIyqVL1-tgUrmxo03Wbcl536NJM30btugS0a4j613wzhqy6vQ-6WR9Fnty5cPoWx1y4eKw9_dWvy5e9HqI-OZhPy1uP5_frC_KzfWXy_VqUxqoRCpNpTlfCgYVMG1a1kJTY6N5zRFMK7AG6CkiZ6YFIwEltF3fYptx0QmxhNPi49F3H_z3CWNSo40Gh0E79FNUXEpWg6x5k9H3f6F3fgoudzdTQtKGVeyR2uoBlXW9T0Gb2VStpBCsboBBps7-QeXV4WiNd9jbfP9E8OEPwQ71kHbRD9P8gvEpyI-gCT7GgL3aBzvqcFCMqjkM6hgGlcOgfoZBzaJ3D6NN7Yjdb8mv388AHIGYS26L4XH2_9j-AFIVu8U</recordid><startdate>2023</startdate><enddate>2023</enddate><creator>Naryzhnaya, N. V.</creator><creator>Sementsov, A. S.</creator><creator>Maslov, L. N.</creator><creator>Derkachev, I. A.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>2023</creationdate><title>The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia</title><author>Naryzhnaya, N. V. ; Sementsov, A. S. ; Maslov, L. N. ; Derkachev, I. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-c5a229413531acb1b386e8a262e3cb4e633f0ee21cb3c73e73bdfbeb5314d4493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analysis</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Coronary artery</topic><topic>General Pathology and Pathological Physiology</topic><topic>Heart</topic><topic>Hemoglobin</topic><topic>Hypoxia</topic><topic>Internal Medicine</topic><topic>Ischemia</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Myocardial Infarction</topic><topic>Myocardial Reperfusion Injury - drug therapy</topic><topic>NG-Nitroarginine methyl ester</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric Oxide Synthase</topic><topic>Pathology</topic><topic>Physiology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reperfusion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Naryzhnaya, N. V.</creatorcontrib><creatorcontrib>Sementsov, A. S.</creatorcontrib><creatorcontrib>Maslov, L. N.</creatorcontrib><creatorcontrib>Derkachev, I. A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Naryzhnaya, N. V.</au><au>Sementsov, A. S.</au><au>Maslov, L. N.</au><au>Derkachev, I. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2023</date><risdate>2023</risdate><volume>174</volume><issue>3</issue><spage>304</spage><epage>307</epage><pages>304-307</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><abstract>We studied the role of NO synthase in the infarct-limiting effect of short-term (SNH) and chronic continuous normobaric hypoxia (CNH). In male Wistar rats, SNH (6 sessions of 10-min hypoxia 8% O2 and 10-min reoxygenation) or CNH (12% O2 for 21 days) was modeled. In 30 min after SNH or 24 h after CNH, the rats were subjected to coronary artery occlusion (45 min) and reperfusion (2 h). The following drugs were administered to rats: non-selective NO synthase inhibitor L-NAME (10 mg/kg), inhibitor of inducible NO synthase S-methylthiourea (3 mg/kg), and inhibitor of neuronal NO-synthase 7-nitroindazole (50 mg/kg). NO donor diethylenetriamine was administered intravenously in a dose 2 mg/kg. It was found that L-NAME and S-methylthiourea abolished the infarct-limiting effect of SNH and CNH. Diethylenetriamine increased cardiac tolerance to ischemia/reperfusion. It is believed that inducible NO synthase plays an important role in the cardioprotective effect of normobaric hypoxia.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36723734</pmid><doi>10.1007/s10517-023-05696-3</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-4888 |
ispartof | Bulletin of experimental biology and medicine, 2023, Vol.174 (3), p.304-307 |
issn | 0007-4888 1573-8221 |
language | eng |
recordid | cdi_proquest_miscellaneous_2771637628 |
source | MEDLINE; SpringerNature Journals |
subjects | Analysis Animals Biomedical and Life Sciences Biomedicine Cell Biology Coronary artery General Pathology and Pathological Physiology Heart Hemoglobin Hypoxia Internal Medicine Ischemia Laboratory Medicine Male Myocardial Infarction Myocardial Reperfusion Injury - drug therapy NG-Nitroarginine methyl ester NG-Nitroarginine Methyl Ester - pharmacology Nitric Oxide Synthase Pathology Physiology Rats Rats, Wistar Reperfusion |
title | The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T22%3A08%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20NO%20Synthase%20in%20the%20Infarct-Limiting%20Effect%20of%20Urgent%20and%20Chronic%20Adaptation%20to%20Normobaric%20Hypoxia&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Naryzhnaya,%20N.%20V.&rft.date=2023&rft.volume=174&rft.issue=3&rft.spage=304&rft.epage=307&rft.pages=304-307&rft.issn=0007-4888&rft.eissn=1573-8221&rft_id=info:doi/10.1007/s10517-023-05696-3&rft_dat=%3Cgale_proqu%3EA744168313%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2774708151&rft_id=info:pmid/36723734&rft_galeid=A744168313&rfr_iscdi=true |